Clinical Trial

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A prospective, randomized, controlled, parallel clinical trial will be conducted at Clinical Oncology and Nuclear Medicine Center at Mansoura University Hospital to assess the efficacy of Itraconazole as an adjuvant therapy in treatment of patients with acute myeloid Leukemia.
Trial Details
NCT Number NCT07069933
Lead Sponsor Mansoura University
Conditions Acute Myeloid Leukemia
Enrollment 50 participants
Start Date 2025-07
Primary Completion 2025-07 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-17